Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance.
Inhaltsverzeichnis
PART I: UNDERSTANDING TUBERCULOSIS (TB) AND ITS CHALLENGES 1. Tuberculosis Drug Discovery: From Evil to Allies 2. Relationship Between Covid-19 and Tuberculosis 3. Advancement in the Diagnosis of Tuberculosis 4. Mechanisms of Drug Resistance in Tuberculosis and Potential Modulation Strategies PART II: NEW FRONTIERS IN TB DRUG DISCOVERY 5. Outsmarting the Superbug: A Look at New Targets for Tuberculosis Treatment 6. Deciphering Antitubercular Drug Pharmacokinetics 7. Structure-Based Drug Design for Tuberculosis PART III: SUCCESS STORIES AND EMERGING HOPE 8. The Journey of Bedaquiline: Revolutionizing Tuberculosis Treatment 9. Delamanid and Pretomanid: From Bench to Bedside 10. Overview of DprE1 Inhibitors and Development of Macozinone and Other Drugs 11. Unleashing the Power Within: Host Directed Therapies Revolutionizing Tuberculosis Treatment PART IV: TOOLS AND TECHNOLOGIES FOR A TB-FREE FUTURE 12. Artificial Intelligence in Tuberculosis Management 13. Novel Drug Delivery Systems for Tuberculosis Treatment PART V: TOWARD A TB-FREE WORLD: VACCINES, BIOMARKERS, AND THE FUTURE 14. Advances in Tuberculosis Control: Vaccines and Biomarkers 15. Future Perspectives and Emerging Strategies in Tuberculosis Drug Discovery